pharma Archive

Johnson & Johnson says people with diabetes don't need to worry about potentially lethal wireless attacks on insulin pumps

Rapid7 security researcher Jay Radcliffe (previously) has Type I diabetes, and has taken a personal interest in rooting out vulnerabilities in the networked, wireless-equipped blood-sugar monitors and insulin-pumps marketed to people with diabetes, repeatedly discovering potentially lethal defects in these devices. Recently, Radcliffe revealed that Johnson & Johnson’s 2008 Animas Onetouch Ping insulin pump did not encrypt communications between it and its remote …